The Amyloidosis Channel on VJHemOnc is an independent medical education platform, supported with funding from Prothena (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ISA 2024 | Comparison of the Simoa and MSD R-PLEX assays to assess serum NfL levels in ATTR amyloidosis
In this video, Milou Berends, MD, PhD, University Medical Center Groningen, Groningen, The Netherlands, shares insights into a study in which two assays used to measure serum neurofilament light chain (NfL) levels in transthyretin (ATTR) amyloidosis were compared. This study demonstrated that the efficacy of both assays was similar. This interview took place at the XIX International Symposium on Amyloidosis (ISA) in Rochester, MN.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
